A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

doi:10.1186/1471-2407-8-169

BMC Cancer

Volume 8

Viewing options:

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Gonçalves A
Esteyries S
Taylor-Smedra B
Lagarde A
Ayadi M
Monges G
Bertucci F
Esterni B
Delpero JR
Turrini O
Lelong B
Viens P
Borg JP
Birnbaum D
Olschwang S
Viret F

on PubMed

Gonçalves A
Esteyries S
Taylor-Smedra B
Lagarde A
Ayadi M
Monges G
Bertucci F
Esterni B
Delpero JR
Turrini O
Lelong B
Viens P
Borg JP
Birnbaum D
Olschwang S
Viret F
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Email this article to a friend

A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

Anthony Gonçalves^* , Séverine Esteyries^* , Brynn Taylor-Smedra , Arnaud Lagarde , Mounay Ayadi , Geneviève Monges , François Bertucci , Benjamin Esterni , Jean-Robert Delpero , Olivier Turrini , Bernard Lelong , Patrice Viens , Jean-Paul Borg , Daniel Birnbaum , Sylviane Olschwang and Frédéric Viret

BMC Cancer 2008, 8:169doi:10.1186/1471-2407-8-169

Your name*
Your email address*
Recipient's email address*	(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:	I thought the following article from BMC Cancer (http://www.biomedcentral.com/home) would be of interest to you.